• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Enanta Pharmaceuticals, Inc. (ENTA)

    -NasdaqGS
    24.39 Up 1.20(5.17%) 4:00PM EDT
    |After Hours : 24.39 0.00 (0.00%) 4:08PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 13,004   48,445   14,416   11,599  
    Cost of Revenue -   -   -   -  
    Gross Profit 13,004   48,445   14,416   11,599  
    Operating Expenses
    Research Development9,143  9,033  7,049  6,253  
    Selling General and Administrative4,426  3,818  3,693  3,643  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (565) 35,594   3,674   1,703  
    Income from Continuing Operations
    Total Other Income/Expenses Net483  341  511  289  
    Earnings Before Interest And Taxes(82)35,935  4,185  1,992  
    Interest Expense11  12  2  2  
    Income Before Tax(93)35,923  4,183  1,990  
    Income Tax Expense1,552  9,734  (1,629)(428)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(1,645)26,189  5,812  2,418  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (1,645) 26,189   5,812   2,418  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (1,645) 26,189   5,812   2,418  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.